Icagen, Inc. (ICGN)
Today, Penny Stock DD reported on Icagen, Inc. (ICGN), Greenbackers did earlier, and we highlight the Company as “One to Watch” next week, here at the QualityStocks Daily Newsletter.
Icagen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small molecule drugs that modulate ion channel targets. The Company has developed an integrated technology platform that enables the efficient discovery of drug leads. Trading on the NASDAQ Global Market, Icagen, Inc. has their corporate headquarters in Durham, North Carolina.
Ion channels are protein structures found in nearly every cell of the human body. These channels span the cell membrane and regulate the flow of ions, charged particles such as sodium, potassium, calcium and chloride, into and out of cells. Currently, there are 35 drugs that modulate ion channels, which are marketed by third parties for multiple therapeutic indications.
(Read the Rest of the Article…)